All Comparisons/Ibex Medical Analytics vs Aiforia

VNDRIQ — Vendor Comparison

Ibex Medical Analytics vs Aiforia

Side-by-side comparison of BAA status, PHI exposure, AI training risk, HIPAA suitability, and VNDRIQ governance scores.

Ibex Medical Analytics47
Aiforia53

Ibex Medical Analytics

Digital Pathology AI

Last verified: September 30, 2026

Aiforia

Digital Pathology AI

Last verified: September 30, 2026

VNDRIQ Scores

47

Overall

Privacy Score36
Governance Score71
Healthcare Readiness49
AI Risk Score30

53

Overall

Privacy Score62
Governance Score33
Healthcare Readiness50
AI Risk Score65

Approval Tier

Approved With Restrictions
Restricted / Review Required

BAA Status

Available upon request for clinical customers
Verify Directly

PHI Exposure Risk

High
Medium

AI Training Risk

High
Medium

HIPAA Risk Level

High
Medium

Review Frequency

Quarterly

—

Recommended Use

Clinical decision support for pathologists in prostate cancer diagnosis using the FDA-cleared Ibex Prostate Detect software.

—

Restrictions

Only Ibex Prostate Detect is FDA-cleared; other solutions (breast, gastric) are Research Use Only (RUO) in the United States.

—

Executive Summary

Ibex Medical Analytics

Digital Pathology AI

Ibex Medical Analytics is classified as Approved With Restrictions with a BAA status of Available upon request for clinical customers. PHI exposure is rated High and AI training risk is High. Clinical decision support for pathologists in prostate cancer diagnosis using the FDA-cleared Ibex Prostate Detect software.

36

Privacy

71

Governance

49

Healthcare

30

AI Risk

Aiforia

Digital Pathology AI

Aiforia is classified as Restricted / Review Required with a BAA status of Verify Directly. PHI exposure is rated Medium and AI training risk is Medium.

62

Privacy

33

Governance

50

Healthcare

65

AI Risk

Recommended For

Ibex Medical Analytics

Clinical decision support for pathologists in prostate cancer diagnosis using the FDA-cleared Ibex Prostate Detect software.

Organizations with established governance workflows

Multi-location healthcare groups needing standardized vendor status

Aiforia

Currently under review — not recommended for active PHI deployment

Governance Considerations

Ibex Medical Analytics

Verify model training opt-out clauses before deployment.

PHI exposure is elevated. Review data flow documentation.

Quarterly reviews are required — establish internal review cadence.

Restrictions noted: Only Ibex Prostate Detect is FDA-cleared; other solutions (breast, gastric) are Research Use Only (RUO) in the United States.

Aiforia

BAA has not been confirmed. Execute BAA before processing PHI.

Questions to Ask Before Approval

01

Has the vendor executed a Business Associate Agreement (BAA) with your organization?

02

Does the vendor use customer data to train AI models? Can you opt out?

03

Where is PHI stored, processed, and transmitted?

04

What data retention and deletion policies apply to your PHI?

05

Has the vendor undergone a third-party HIPAA or SOC 2 audit?

06

What is the vendor's incident response and breach notification process?

07

Does the vendor offer audit logging for PHI access?

08

What subprocessors have access to PHI through this vendor?

Request Vendor Evaluation

Get a structured risk assessment for any vendor.

Request Benchmark Report

Compare vendors across your full stack.

Book Governance Assessment

Talk to a VNDRIQ governance specialist.